Related Experiment Video

Updated: Dec 9, 2025

Author Spotlight: Developing Tools to Tune the Activity of Tyrosine Phosphatases
06:56

Author Spotlight: Developing Tools to Tune the Activity of Tyrosine Phosphatases

Published on: September 6, 2024

606

The Role of Ras-Associated Protein 1 (Rap1) in Cancer: Bad Actor or Good Player?

Chin-King Looi1, Ling-Wei Hii1,2, Siew Ching Ngai3

  • 1School of Postgraduate Study, International Medical University, Bukit Jalil, Kuala Lumpur 57000, Malaysia.

Biomedicines
|September 10, 2020
PubMed

Insights

Targeting Ras-associated protein1 (Rap1) signaling, which promotes cancer progression and immune evasion, could be a promising therapeutic strategy. Inhibiting Rap1 activity via Rap1GAP may offer new avenues for cancer treatment.

Area of Science:

  • Oncology
  • Immunology
  • Molecular Biology

Background:

  • Metastasis is a critical factor in cancer patient mortality.
  • T cell dysfunction can promote tumor proliferation and metastasis.
  • Constitutive Ras-associated protein1 (Rap1) activation is linked to T cell anergy, inhibited autophagy, and cancer progression.

Purpose of the Study:

  • To investigate the role of Rap1 signaling in cancer progression and metastasis.
  • To evaluate the therapeutic potential of targeting Rap1 and its regulators, such as Rap1GAP.

Main Methods:

  • Analysis of Rap1 signaling pathways in cancer cells.
  • Assessment of Rap1GAP as a negative regulator of Rap1 activity.
  • Evaluation of the impact of Rap1 inhibition on tumor progression, invasion, and immune evasion.

Main Results:

  • Constitutive Rap1 activation contributes to T cell dysfunction and cancer progression.
  • Inhibition of Rap1 activity by Rap1GAP impairs tumor progression.
  • Rap1 signaling exhibits pleiotropic and cancer-specific effects on tumor invasion.
  • Targeting Rap1 may overcome chemoresistance and immune evasion.

Conclusions:

  • Rap1 signaling plays a complex role in cancer, with context-dependent effects.
  • Rap1GAP represents a potential therapeutic target for controlling cancer, metastasis, and immune evasion.
  • Modulating Rap1 signaling could offer a novel strategy for cancer therapy.
Keywords:
Rap1Rap1GAPtumor initiationtumor progression

More Related Videos

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods07:49

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods

Published on: July 17, 2019

6.4K
Author Spotlight: Integrating BRET-Based Assays and Rare Mutation Analysis to Decipher RAF Kinase Regulation in Live Cells06:44

Author Spotlight: Integrating BRET-Based Assays and Rare Mutation Analysis to Decipher RAF Kinase Regulation in Live Cells

Published on: March 1, 2024

1.5K

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
6.9K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
5.0K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.5K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.0K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.9K